Jun Cui

15.2k citations

163 papers · 8.6k indexed · 2 hit papers · h-index 51

Impact in

Immunology top 0.5%
- interferon and immune responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immune cells in cancer
Cancer Research top 1%

Papers in ⓘ

Immunology 81
- interferon and immune responses 46
- Immune Response and Inflammation 26
- Immune Cell Function and Interaction 15
- Immune cells in cancer 14
Cancer Research 28
- NF-κB Signaling Pathways 14

Co-authors: Rong‐Fu Wang (21 shared papers)Helen Y. Wang (11 shared papers)Shouheng Jin (34 shared papers)Weihong Xie (22 shared papers)Yaoxing Wu (29 shared papers)Yunfei Qin (13 shared papers)Pingping Shen (12 shared papers)Tao Liu (9 shared papers)
Journals: Autophagy (15 papers)Nature Communications (8 papers)Molecular Cell (6 papers)The EMBO Journal (5 papers)Cell Reports (4 papers)
Partner nations: China United States Australia

In The Last Decade

Jun Cui

153 papers receiving 8.5k citations

Hit Papers

align trajectories log scale

Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity 2025 · 19 citations

Peers

Countries citing papers authored by Jun Cui

Since Specialization

Citations

This map shows the geographic impact of Jun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Cui more than expected).

Fields of papers citing papers by Jun Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Cui. The network helps show where Jun Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Cui Line = papers co-authored together Jun Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways Cell ·Jun Cui, Liang Zhu, Xiaojun Xia, Helen Y. Wang, Xavier Legras, Jun Ki Hong, Jiabing Ji, Pingping Shen, Shu Zheng, Zhijian J. Chen, Rong‐Fu Wang	2010	361
2	TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses Molecular Cell ·Meixin Chen, Qingcai Meng, Yunfei Qin, Puping Liang, Peng Tan, Lian He, Yubin Zhou, Yongjun Chen, Junjiu Huang, Rong‐Fu Wang, Jun Cui	2016	296
3	Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma Oncotarget ·Shu-Biao Ye, Ze-Lei Li, Dong-Hua Luo, Bi-Jun Huang, Yu-Suan Chen, Xiao-Shi Zhang, Jun Cui, Yi-Xin Zeng, Jiang Li	2014	290
4	CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation Nature Communications ·Tiantian Tang, Xueting Lang, Cong‐Fei Xu, Xiaqiong Wang, Tao Gong, Yanqing Yang, Jun Cui, Li Bai, Jun Wang, Wei Jiang, Rongbin Zhou	2017	283
5	Mechanisms and pathways of innate immune activation and regulation in health and cancer Human Vaccines & Immunotherapeutics ·Jun Cui, Yongjun Chen, Helen Y. Wang, Rong‐Fu Wang	2014	238
6	NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK Immunity ·Xiaojun Xia, Jun Cui, Helen Y. Wang, Liang Zhu, Satoko Matsueda, Qinfu Wang, Xiaoang Yang, Jun Ki Hong, Zhou Songyang, Zhijian J. Chen, Rongfu Wang	2011	235
7	NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4 Nature Immunology ·Jun Cui, Yinyin Li, Liang Zhu, Dan Liu, Zhou Songyang, Helen Y. Wang, Rong‐Fu Wang	2012	232
8	CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer Oncogene ·Huanling Zhang, Y-L Ye, M-X Li, S-B Ye, W-R Huang, T-T Cai, Jia He, J-Y Peng, Tao Duan, Jun Cui, X-S Zhang, F-J Zhou, R.F. Wang, Jiang Li	2016	219
9	Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro Cell Discovery ·Yaoxing Wu, Qingxiang Liu, Jie Zhou, Weihong Xie, Cheng Chen, Zefang Wang, Haitao Yang, Jun Cui	2017	177
10	Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs Proceedings of the National Academy of Sciences ·Zhe Li, Xin Li, Yi-You Huang, Yaoxing Wu, Runduo Liu, Lingli Zhou, Yuxi Lin, Deyan Wu, Lei Zhang, Hao Liu, Ximing Xu, Kunqian Yu, Yuxia Zhang, Jun Cui, Chang‐Guo Zhan, Xin Wang, Hai‐Bin Luo	2020	177
11	Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS 1‐caspase‐1 axis The EMBO Journal ·Yanyan Zheng, Qingxiang Liu, Yaoxing Wu, Ling Ma, Zhenzhen Zhang, Tao Liu, Shouheng Jin, Yuanchu She, Yi‐Ping Li, Jun Cui	2018	172
12	USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy Cellular and Molecular Immunology ·Tao Liu, Liqiu Wang, Puping Liang, Xiaojuan Wang, Yukun Liu, Jing Cai, Yuanchu She, Dan Wang, Zhi Wang, Zhiyong Guo, Samuel Bates, Xiaojun Xia, Junjiu Huang, Jun Cui	2020	169
13	Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells Molecular Cell ·Shouheng Jin, Shuo Tian, Man Luo, Weihong Xie, Tao Liu, Tianhao Duan, Yaoxing Wu, Jun Cui	2017	168
14	Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome Nature Communications ·Liqiu Wang, Tao Liu, Shuai Yang, Lin Sun, Zhiyao Zhao, Li-Yue Li, Yuanchu She, Yanyan Zheng, Xiaoyan Ye, Qing Bao, Guang‐Hui Dong, Chunwei Li, Jun Cui	2021	167
15	USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors Cell Research ·Jun Cui, Yanxia Song, Yinyin Li, Qingyuan Zhu, Peng Tan, Yunfei Qin, Helen Y. Wang, Rong‐Fu Wang	2013	152
16	Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy Molecular Cell ·Liqiu Wang, Jing Cai, Xin Zhao, Ling Ma, Ping Zeng, Lingli Zhou, Yukun Liu, Shuai Yang, Zhe Cai, Song Zhang, Liang Zhou, Jiahui Yang, Tao Liu, Shouheng Jin, Jun Cui Hit paper breakdown →	2022	150
17	USP 19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin‐1 The EMBO Journal ·Shouheng Jin, Shuo Tian, Yamei Chen, Chuanxia Zhang, Weihong Xie, Xiaojun Xia, Jun Cui, Rong‐Fu Wang	2016	146
18	Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome Cancer Research ·Xi Wang, Yiqun Jia, Liling Wen, Wenxin Mu, Xianrui Wu, Tao Liu, Xiangqi Liu, Juan Fang, Yizhao Luan, Ping Chen, Jinlong Gao, Ky‐Anh Nguyen, Jun Cui, Gucheng Zeng, Ping Lan, Qianming Chen, Bin Cheng, Zhi Wang	2021	145
19	TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy Cell Reports ·Tao Liu, Qin Tang, Kunpeng Liu, Weihong Xie, Xin Liu, Huishan Wang, Rong‐Fu Wang, Jun Cui	2016	140
20	LRRC25 inhibits type I IFN signaling by targeting ISG15‐associated RIG‐I for autophagic degradation The EMBO Journal ·Yang Du, Tianhao Duan, Yan‐Chun Feng, Qingxiang Liu, Meng Lin, Jun Cui, Rong‐Fu Wang	2017	139

About Jun Cui

Jun Cui is a scholar working on Immunology, Cancer Research, Physiology, Molecular Biology and Parasitology, having authored 163 papers that have together received 8.6k indexed citations. Recurring topics across this work include interferon and immune responses (46 papers), Autophagy in Disease and Therapy (33 papers), Inflammasome and immune disorders (27 papers), Immune Response and Inflammation (26 papers), Immune Cell Function and Interaction (15 papers), NF-κB Signaling Pathways (14 papers), Immune cells in cancer (14 papers) and Ubiquitin and proteasome pathways (12 papers). The work is most often cited by research in Immunology (3.8k citations), Cancer Research (1.3k citations), Molecular Biology (4.7k citations), Infectious Diseases (962 citations) and Oncology (1.2k citations). Jun Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Rong‐Fu Wang, Helen Y. Wang, Shouheng Jin, Weihong Xie, Yaoxing Wu, Yunfei Qin, Pingping Shen, Tao Liu, Xiaojun Xia and Qingxiang Liu. Their work appears in journals such as Autophagy, Nature Communications, Molecular Cell, The EMBO Journal and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact